0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hormone Patch Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1J14690
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Hormone Patch Market Research Report 2023
BUY CHAPTERS

Global Hormone Patch Market Research Report 2025

Code: QYRE-Auto-1J14690
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hormone Patch Market

The global market for Hormone Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Hormone Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hormone Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hormone Patch include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hormone Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormone Patch.
The Hormone Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hormone Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormone Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hormone Patch Market Report

Report Metric Details
Report Name Hormone Patch Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, Zhejiang Yatai Pharmaceutical Company Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hormone Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hormone Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hormone Patch Market report?

Ans: The main players in the Hormone Patch Market are Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, Zhejiang Yatai Pharmaceutical Company Ltd.

What are the Application segmentation covered in the Hormone Patch Market report?

Ans: The Applications covered in the Hormone Patch Market report are Hospital, Clinic

What are the Type segmentation covered in the Hormone Patch Market report?

Ans: The Types covered in the Hormone Patch Market report are Contraceptive Patch, Estradiol Patch, Others

Recommended Reports

Hormone Therapy Markets

Medical Patch Devices

Transdermal Delivery Systems

1 Hormone Patch Market Overview
1.1 Product Definition
1.2 Hormone Patch by Type
1.2.1 Global Hormone Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Contraceptive Patch
1.2.3 Estradiol Patch
1.2.4 Others
1.3 Hormone Patch by Application
1.3.1 Global Hormone Patch Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Hormone Patch Market Size Estimates and Forecasts
1.4.1 Global Hormone Patch Revenue 2020-2031
1.4.2 Global Hormone Patch Sales 2020-2031
1.4.3 Global Hormone Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hormone Patch Market Competition by Manufacturers
2.1 Global Hormone Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hormone Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hormone Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hormone Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hormone Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormone Patch, Product Type & Application
2.7 Global Key Manufacturers of Hormone Patch, Date of Enter into This Industry
2.8 Global Hormone Patch Market Competitive Situation and Trends
2.8.1 Global Hormone Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hormone Patch Players Market Share by Revenue
2.8.3 Global Hormone Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hormone Patch Market Scenario by Region
3.1 Global Hormone Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hormone Patch Sales by Region: 2020-2031
3.2.1 Global Hormone Patch Sales by Region: 2020-2025
3.2.2 Global Hormone Patch Sales by Region: 2026-2031
3.3 Global Hormone Patch Revenue by Region: 2020-2031
3.3.1 Global Hormone Patch Revenue by Region: 2020-2025
3.3.2 Global Hormone Patch Revenue by Region: 2026-2031
3.4 North America Hormone Patch Market Facts & Figures by Country
3.4.1 North America Hormone Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hormone Patch Sales by Country (2020-2031)
3.4.3 North America Hormone Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hormone Patch Market Facts & Figures by Country
3.5.1 Europe Hormone Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hormone Patch Sales by Country (2020-2031)
3.5.3 Europe Hormone Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormone Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Hormone Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hormone Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Hormone Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hormone Patch Market Facts & Figures by Country
3.7.1 Latin America Hormone Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hormone Patch Sales by Country (2020-2031)
3.7.3 Latin America Hormone Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormone Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Hormone Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hormone Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hormone Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hormone Patch Sales by Type (2020-2031)
4.1.1 Global Hormone Patch Sales by Type (2020-2025)
4.1.2 Global Hormone Patch Sales by Type (2026-2031)
4.1.3 Global Hormone Patch Sales Market Share by Type (2020-2031)
4.2 Global Hormone Patch Revenue by Type (2020-2031)
4.2.1 Global Hormone Patch Revenue by Type (2020-2025)
4.2.2 Global Hormone Patch Revenue by Type (2026-2031)
4.2.3 Global Hormone Patch Revenue Market Share by Type (2020-2031)
4.3 Global Hormone Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hormone Patch Sales by Application (2020-2031)
5.1.1 Global Hormone Patch Sales by Application (2020-2025)
5.1.2 Global Hormone Patch Sales by Application (2026-2031)
5.1.3 Global Hormone Patch Sales Market Share by Application (2020-2031)
5.2 Global Hormone Patch Revenue by Application (2020-2031)
5.2.1 Global Hormone Patch Revenue by Application (2020-2025)
5.2.2 Global Hormone Patch Revenue by Application (2026-2031)
5.2.3 Global Hormone Patch Revenue Market Share by Application (2020-2031)
5.3 Global Hormone Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mylan Pharmaceuticals Inc.(Viatris)
6.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Information
6.1.2 Mylan Pharmaceuticals Inc.(Viatris) Description and Business Overview
6.1.3 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolio
6.1.5 Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
6.2 Twirla
6.2.1 Twirla Company Information
6.2.2 Twirla Description and Business Overview
6.2.3 Twirla Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Twirla Hormone Patch Product Portfolio
6.2.5 Twirla Recent Developments/Updates
6.3 Novartis(HEXAL AG)
6.3.1 Novartis(HEXAL AG) Company Information
6.3.2 Novartis(HEXAL AG) Description and Business Overview
6.3.3 Novartis(HEXAL AG) Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis(HEXAL AG) Hormone Patch Product Portfolio
6.3.5 Novartis(HEXAL AG) Recent Developments/Updates
6.4 Bayer Healthcare Pharmaceuticals
6.4.1 Bayer Healthcare Pharmaceuticals Company Information
6.4.2 Bayer Healthcare Pharmaceuticals Description and Business Overview
6.4.3 Bayer Healthcare Pharmaceuticals Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolio
6.4.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
6.5 Noven
6.5.1 Noven Company Information
6.5.2 Noven Description and Business Overview
6.5.3 Noven Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Noven Hormone Patch Product Portfolio
6.5.5 Noven Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Company Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie Hormone Patch Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical Co., Inc.
6.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.7.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.7.3 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.8 Watson Pharmaceuticals
6.8.1 Watson Pharmaceuticals Company Information
6.8.2 Watson Pharmaceuticals Description and Business Overview
6.8.3 Watson Pharmaceuticals Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Watson Pharmaceuticals Hormone Patch Product Portfolio
6.8.5 Watson Pharmaceuticals Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Hormone Patch Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 ANI Pharmaceuticals
6.10.1 ANI Pharmaceuticals Company Information
6.10.2 ANI Pharmaceuticals Description and Business Overview
6.10.3 ANI Pharmaceuticals Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ANI Pharmaceuticals Hormone Patch Product Portfolio
6.10.5 ANI Pharmaceuticals Recent Developments/Updates
6.11 Zhejiang Yatai Pharmaceutical Company Ltd.
6.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
6.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Description and Business Overview
6.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolio
6.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormone Patch Industry Chain Analysis
7.2 Hormone Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormone Patch Production Mode & Process Analysis
7.4 Hormone Patch Sales and Marketing
7.4.1 Hormone Patch Sales Channels
7.4.2 Hormone Patch Distributors
7.5 Hormone Patch Customer Analysis
8 Hormone Patch Market Dynamics
8.1 Hormone Patch Industry Trends
8.2 Hormone Patch Market Drivers
8.3 Hormone Patch Market Challenges
8.4 Hormone Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hormone Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hormone Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hormone Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hormone Patch Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hormone Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hormone Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hormone Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hormone Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hormone Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hormone Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hormone Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Hormone Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hormone Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hormone Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hormone Patch Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hormone Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Hormone Patch Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hormone Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Hormone Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hormone Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Hormone Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hormone Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Hormone Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hormone Patch Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hormone Patch Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hormone Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hormone Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hormone Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hormone Patch Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hormone Patch Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hormone Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hormone Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hormone Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hormone Patch Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hormone Patch Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hormone Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hormone Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hormone Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hormone Patch Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hormone Patch Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hormone Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hormone Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hormone Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hormone Patch Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hormone Patch Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hormone Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hormone Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hormone Patch Sales (K Units) by Type (2020-2025)
 Table 51. Global Hormone Patch Sales (K Units) by Type (2026-2031)
 Table 52. Global Hormone Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Hormone Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Hormone Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hormone Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hormone Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Hormone Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Hormone Patch Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hormone Patch Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hormone Patch Sales (K Units) by Application (2020-2025)
 Table 61. Global Hormone Patch Sales (K Units) by Application (2026-2031)
 Table 62. Global Hormone Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Hormone Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Hormone Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hormone Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hormone Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Hormone Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Hormone Patch Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hormone Patch Price (US$/Unit) by Application (2026-2031)
 Table 70. Mylan Pharmaceuticals Inc.(Viatris) Company Information
 Table 71. Mylan Pharmaceuticals Inc.(Viatris) Description and Business Overview
 Table 72. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product
 Table 74. Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
 Table 75. Twirla Company Information
 Table 76. Twirla Description and Business Overview
 Table 77. Twirla Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Twirla Hormone Patch Product
 Table 79. Twirla Recent Developments/Updates
 Table 80. Novartis(HEXAL AG) Company Information
 Table 81. Novartis(HEXAL AG) Description and Business Overview
 Table 82. Novartis(HEXAL AG) Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis(HEXAL AG) Hormone Patch Product
 Table 84. Novartis(HEXAL AG) Recent Developments/Updates
 Table 85. Bayer Healthcare Pharmaceuticals Company Information
 Table 86. Bayer Healthcare Pharmaceuticals Description and Business Overview
 Table 87. Bayer Healthcare Pharmaceuticals Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Healthcare Pharmaceuticals Hormone Patch Product
 Table 89. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
 Table 90. Noven Company Information
 Table 91. Noven Description and Business Overview
 Table 92. Noven Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Noven Hormone Patch Product
 Table 94. Noven Recent Developments/Updates
 Table 95. AbbVie Company Information
 Table 96. AbbVie Description and Business Overview
 Table 97. AbbVie Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AbbVie Hormone Patch Product
 Table 99. AbbVie Recent Developments/Updates
 Table 100. Hisamitsu Pharmaceutical Co., Inc. Company Information
 Table 101. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
 Table 102. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product
 Table 104. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
 Table 105. Watson Pharmaceuticals Company Information
 Table 106. Watson Pharmaceuticals Description and Business Overview
 Table 107. Watson Pharmaceuticals Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Watson Pharmaceuticals Hormone Patch Product
 Table 109. Watson Pharmaceuticals Recent Developments/Updates
 Table 110. Johnson & Johnson Company Information
 Table 111. Johnson & Johnson Description and Business Overview
 Table 112. Johnson & Johnson Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Johnson & Johnson Hormone Patch Product
 Table 114. Johnson & Johnson Recent Developments/Updates
 Table 115. ANI Pharmaceuticals Company Information
 Table 116. ANI Pharmaceuticals Description and Business Overview
 Table 117. ANI Pharmaceuticals Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. ANI Pharmaceuticals Hormone Patch Product
 Table 119. ANI Pharmaceuticals Recent Developments/Updates
 Table 120. Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
 Table 121. Zhejiang Yatai Pharmaceutical Company Ltd. Description and Business Overview
 Table 122. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product
 Table 124. Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Hormone Patch Distributors List
 Table 128. Hormone Patch Customers List
 Table 129. Hormone Patch Market Trends
 Table 130. Hormone Patch Market Drivers
 Table 131. Hormone Patch Market Challenges
 Table 132. Hormone Patch Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hormone Patch
 Figure 2. Global Hormone Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hormone Patch Market Share by Type: 2024 & 2031
 Figure 4. Contraceptive Patch Product Picture
 Figure 5. Estradiol Patch Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Hormone Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Hormone Patch Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Hormone Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hormone Patch Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hormone Patch Sales (2020-2031) & (K Units)
 Figure 14. Global Hormone Patch Average Price (US$/Unit) & (2020-2031)
 Figure 15. Hormone Patch Report Years Considered
 Figure 16. Hormone Patch Sales Share by Manufacturers in 2024
 Figure 17. Global Hormone Patch Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hormone Patch Players: Market Share by Revenue in Hormone Patch in 2024
 Figure 19. Hormone Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hormone Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hormone Patch Sales Market Share by Country (2020-2031)
 Figure 22. North America Hormone Patch Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hormone Patch Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hormone Patch Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hormone Patch Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hormone Patch Revenue Market Share by Region (2020-2031)
 Figure 34. China Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Hormone Patch Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Hormone Patch Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Hormone Patch Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Hormone Patch Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Hormone Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Hormone Patch by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Hormone Patch by Type (2020-2031)
 Figure 53. Global Hormone Patch Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Hormone Patch by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Hormone Patch by Application (2020-2031)
 Figure 56. Global Hormone Patch Price (US$/Unit) by Application (2020-2031)
 Figure 57. Hormone Patch Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture